, Volume 252, Issue 1, pp 49-53

Influence on erythropoietin levels of treatment with cisplatinum-endoxan

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Erythropoietin levels have been determined in 24 patients with different gynecologic malignancies, who were treated with cisplatinum and endoxan. A statistically highly significant decrease was demonstrated 2 h after starting treatment with a further significant decrease at 6 h. After 12 h the erythropoietin concentrations returned to values similar to those before treatment started.

Dedicated to Prof. Dr. P. Dittrich in honour of his 65th anniversary